News

The range of alternatives that will be assessed could include minority investment or strategic alliance, a merger or sale of some or all of Prosidion’s assets. Oxford-based Prosidion

The data analysis used the recently introduced SeqSolve Next Generation Sequencing (NGS) functional bioinformatics analysis software and Direct RNA Sequencing. The SeqSolve analysis software is an independent, multi-organism

With this tie up Greenway Medical is expected to integrate DiagnosisONE’s CDS solutions into its EHR solution to deliver real-time, patient-specific alerts at the point of care. Greenway

The proof of concept study will evaluate the potential to achieve sustained viral response 24 weeks post treatment with an oral, once-daily treatment regimen in patients across HCV

The study compares elvitegravir to Merck & Co’s drug Isentress, and will now last 96 weeks instead of 48 weeks, reported Bloomberg.com. Gilead said the extension will allow

The milestone was triggered by the initiation of a Phase 2 clinical study evaluating BAY 86-9766 in combination with sorafenib (Nexavar; Bayer, Onyx Pharmaceuticals) for the treatment of

As per the agreement, GSK will pay research funding as well as a sum of $20m as an upfront payment to Epizyme. Additionally, GSK is also responsible to

Watson Pharma said that the approved drug is generic equivalent to Cephalon’s Fentora tablets. Fentora is used to treat breakthrough pain in adult patients with cancer (18 years

Emerald and UCB had initiated their collaboration partnership in January 2009. Under the agreement, both the companies have identiified a series of small molecules and have solved high-resolution